Newsletter
Federal scheduling process has “gaps” amid ongoing marijuana review (Newsletter: September 24, 2026)
Cannabis list as “high-risk” product in new congressional bill; Anti-drug group pushes hemp recriminalization; DEA vs. FDA on psychedelics
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.
Support our work at https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
A new Government Accountability Office report concluded that federal agencies’ policies that govern the drug scheduling process have “gaps” that “may pose a risk”—a finding that comes as the Drug Enforcement Administration is considering broadly rescheduling marijuana.
- “DEA does not have any policies or procedures regarding how its staff are to conduct evaluations or schedule substances.”
Rep. Valerie Foushee (D-NC) and Del. James Moylan (R-Guam) filed a bill aimed at protecting consumers from online scams that includes a provision designating cannabis as a “high-risk” product that would require companies advertising it to undergo enhanced verification procedures.
The Community Anti-Drug Coalitions of America’s 2026 elections guide includes two questions about banning hemp THC products that it wants congressional candidates to answer before November.
The Drug Enforcement Administration is moving to place five psychedelics in Schedule I as the Food and Drug Administration moves in the other direction by taking steps to accelerate therapeutic access to psychedelics.
The Missouri Supreme Court heard oral arguments in case on whether regulators should be forced to award marijuana business licenses to a company in light of inconsistent application scoring procedures.
/ FEDERAL
Veterans Affairs Secretary Doug Collins met with the CEO of Americans for Ibogaine.
The Internal Revenue Service filed a brief before a federal appeals court defending its rejection of a marijuana business’s tax deduction.
Maine Republican congressional candidate Paul LePage, a former governor, said he opposes legalizing marijuana.
Nebraska congressional candidates outlined their views on federal marijuana rescheduling.
/ STATES
A Nebraska court is considering a cannabis business’s challenge to a civil investigative demand issued the state’s attorney general.
Indiana officials published guidance about identifying cannabis-infused foods.
A Minnesota cannabis regulator discussed the racist roots of prohibition.
An Ohio marijuana regulatory spokesperson said that their role is not to oversee hemp products.
California regulators sent updates about various cannabis issues.
The Michigan Cannabis Regulatory Agency will hold a public meeting on Thursday.
The U.S. Virgin Islands Cannabis Advisory board will meet on Thursday.
Oregon regulators will discuss lifting a moratorium on certain marijuana business license types on Friday.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
The Oshkosh, Wisconsin Common Council voted to set an age limit of 21 for hemp THC products.
/ INTERNATIONAL
The Ontario, Canada Court of Appeal ruled that a vape pen with a THC sticker in a man’s car gave police reasonable grounds for a search.
/ SCIENCE & HEALTH
A review concluded that “preclinical evidence supporting CBD as a treatment for [alcohol use disorder] remains strong, while emerging human data are mixed.”
A study found “preclinical evidence that CBD exerts potent anti-tumor activity in” non-small cell lung cancer.
/ ADVOCACY, OPINION & ANALYSIS
Americans for Tax Reform highlighted Michigan Republican gubernatorial candidate John James’s pledge to cut marijuana taxes.
/ BUSINESS
Curaleaf Holdings, Inc. was added to the FTSE Canada All Cap Index.
IM Cannabis Corp. entered into securities purchase agreements for the sale of shares for gross proceeds of approximately$1.31 million.
/ CULTURE
Woody Harrelson gifted Jimmy Kimmel a giant joint from his cannabis dispensary.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Mike Latimer.
